scholarly article | Q13442814 |
P356 | DOI | 10.1002/PATH.2997 |
P698 | PubMed publication ID | 22009689 |
P50 | author | Pierre Busson | Q61149505 |
Kwong Wai Choy | Q90556214 | ||
Ka Fai To | Q99551275 | ||
Grace Tin-Yun Chung | Q123516778 | ||
Samantha Wei-Man Lun | Q123516779 | ||
P2093 | author name string | Chit Chow | |
Sai-Wah Tsao | |||
Kwok-Wai Lo | |||
Anthony Wing-Hung Chan | |||
Jan Wai-Ying Hui | |||
Timothy Tak-Chun Yip | |||
Cheuk-Him Man | |||
P2860 | cites work | Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling | Q24597245 |
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis | Q24676117 | ||
Therapeutic antibody targeting of individual Notch receptors | Q27660544 | ||
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia | Q29614659 | ||
Targeting specific regions of the Notch3 ligand-binding domain induces apoptosis and inhibits tumor growth in lung cancer | Q33523430 | ||
Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma | Q33594982 | ||
Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin | Q34086841 | ||
Focus on nasopharyngeal carcinoma | Q35773862 | ||
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia | Q36448329 | ||
An auto-regulatory loop for EBV LMP2A involves activation of Notch | Q36528115 | ||
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. | Q37171008 | ||
Rational targeting of Notch signaling in cancer | Q37256451 | ||
Nasopharyngeal carcinoma: the next challenges | Q37745500 | ||
Notch signaling in solid tumors. | Q37785204 | ||
Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer | Q38435843 | ||
Notch3 gene amplification in ovarian cancer | Q39759149 | ||
NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells | Q40002536 | ||
Aberrant activation of notch signaling in human breast cancer | Q40322042 | ||
Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma | Q40372899 | ||
RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma | Q40577439 | ||
Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. | Q40725514 | ||
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus | Q40934947 | ||
Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma | Q42507253 | ||
Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. | Q52833887 | ||
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. | Q53529945 | ||
The Detection of thec-mycandrasOncogenes in Nasopharyngeal Carcinoma by Immunohistochemistry | Q58068928 | ||
P433 | issue | 3 | |
P921 | main subject | cisplatin | Q412415 |
P304 | page(s) | 471-481 | |
P577 | publication date | 2011-10-19 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma | |
P478 | volume | 226 |
Q37621332 | Activation of the NOTCH pathway in head and neck cancer |
Q38249887 | Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma |
Q35522043 | Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study |
Q39123741 | Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. |
Q34712473 | Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells |
Q28082510 | Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers |
Q39112082 | Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells |
Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
Q87411967 | Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer |
Q54256882 | High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC. |
Q34200710 | Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. |
Q42365327 | Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells |
Q38048861 | Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses |
Q38800788 | Investigational drugs for head and neck cancer |
Q36081114 | MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma |
Q35021721 | NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR. |
Q38717772 | Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis. |
Q36039869 | Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma |
Q64997571 | Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma. |
Q34973323 | The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo |
Q87907785 | The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma |
Q52603823 | The Role of Notch3 in Cancer. |
Q33889468 | VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). |
Q58582633 | γ-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling |